CEP
IMGN

Chicago Equity Partners’s Immunogen Inc IMGN Stock Holding History

Chicago Equity Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-85,660
Closed -$437K – 905
2019
Q4 		$437K Sell
85,660
-41,645
-33% -$141K 0.03% 668
2019
Q3 		$308K Buy
+127,305
New +$338K 0.01% 770
2018
Q4 		– Sell
-50,006
Closed -$474K – 900
2018
Q3 		$474K Sell
50,006
-476,654
-91% -$4.58M 0.01% 664
2018
Q2 		$5.12M Buy
526,660
+22,895
+5% +$241K 0.16% 179
2018
Q1 		$5.3M Buy
503,765
+14,730
+3% +$145K 0.17% 175
2017
Q4 		$3.13M Sell
489,035
-1,600
-0.3% -$9.87K 0.1% 277
2017
Q3 		$3.75M Buy
490,635
+272,315
+125% +$1.81M 0.12% 242
2017
Q2 		$1.55M Buy
+218,320
New +$999K 0.04% 415

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Chicago Equity Partners's IMGN Position: Q1 2020 in Review

Chicago Equity Partners sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 85,660 shares — an estimated $437K sold.

Chicago Equity Partners first reported a position in IMGN in Q2 2017 and held it in 8 quarters. The position peaked at $5.3M in Q1 2018. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

  • Chicago Equity Partners reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 85,660 Immunogen Inc shares in Q1 2020, an estimated $437K.
  • Chicago Equity Partners first reported a position in Immunogen Inc in Q2 2017 and held it in 8 quarters.
  • Chicago Equity Partners's Immunogen Inc position peaked at $5.3M in Q1 2018.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.